Ideaya Biosciences Inc (NASDAQ: IDYA) is -25.49% lower on its value in year-to-date trading and has touched a low of $13.45 and a high of $44.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IDYA stock was last observed hovering at around $19.63 in the last trading session, with the day’s loss setting it -0.48%.
Currently trading at $19.15, the stock is 1.97% and 7.39% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.46 million and changing -2.45% at the moment leaves the stock -26.25% off its SMA200. IDYA registered -52.72% loss for a year compared to 6-month loss of -28.12%. The firm has a 50-day simple moving average (SMA 50) of $17.8318 and a 200-day simple moving average (SMA200) of $25.9675.
The stock witnessed a 2.79% gain in the last 1 month and extending the period to 3 months gives it a -11.87%, and is 11.99% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.24% over the week and 6.29% over the month.
Ideaya Biosciences Inc (IDYA) has around 131 employees, a market worth around $1.68B and $7.00M in sales. Profit margin for the company is -4386.90%. Distance from 52-week low is 42.38% and -56.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-29.25%).
The EPS is expected to grow by 5.84% this year
292.0 institutions hold shares in Ideaya Biosciences Inc (IDYA), with institutional investors hold 113.30% of the company’s shares. The shares outstanding are 87.57M, and float is at 78.78M with Short Float at 13.81%. Institutions hold 112.27% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.27 million shares valued at $395.69 million. The investor’s holdings represent 14.4557 of the IDYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.81 million shares valued at $239.02 million to account for 8.7321 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 4.86 million shares representing 6.2283 and valued at over $170.49 million, while VANGUARD GROUP INC holds 5.4728 of the shares totaling 4.27 million with a market value of $149.81 million.
Ideaya Biosciences Inc (IDYA) Insider Activity
Ideaya Biosciences Inc disclosed in a document filed with the SEC on May 29 ’24 that WHITE MICHAEL ANTHONY (Chief Scientific Officer) sold a total of 28,500 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $36.24 per share for $1.03 million. Following the transaction, the insider now directly holds 0.0 shares of the IDYA stock.
